{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:09:10Z","timestamp":1767665350264,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pmr.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T19:52:54Z","timestamp":1527537174000},"page":"455-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Special Considerations in Pediatric Assessment"],"prefix":"10.1016","volume":"29","author":[{"given":"Heakyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Ran","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pmr.2018.03.002_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2872","article-title":"Birth prevalence of cerebral palsy: a population-based study","volume":"137","author":"Van Naarden Braun","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.pmr.2018.03.002_bib2","doi-asserted-by":"crossref","first-page":"317047","DOI":"10.1155\/2015\/317047","article-title":"Spasticity and its contribution to hypertonia in cerebral palsy","volume":"2015","author":"Bar-On","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.pmr.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fneur.2010.00149","article-title":"Spasticity mechanisms - for the clinician","volume":"1","author":"Mukherjee","year":"2010","journal-title":"Front Neurol"},{"key":"10.1016\/j.pmr.2018.03.002_bib4","series-title":"Principles of neurological surgery","first-page":"757","article-title":"Spasticity","author":"Levitt","year":"2012"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01202412-200507000-00007","article-title":"Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity","volume":"14","author":"Hagglund","year":"2005","journal-title":"J\u00a0Pediatr Orthop B"},{"issue":"12","key":"10.1016\/j.pmr.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1212\/WNL.30.12.1303","article-title":"The control of muscle tone, reflexes, and movement: Robert Wartenberg lecture","volume":"30","author":"Lance","year":"1980","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pmr.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mrdd.10032","article-title":"Cerebral palsy in very preterm infants: new epidemiological insights","volume":"8","author":"O'Shea","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.002_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5435\/00124635-199807000-00002","article-title":"Cervical spine disorders in infants and children","volume":"6","author":"Copley","year":"1998","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"10","key":"10.1016\/j.pmr.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1469-8749.2012.04385.x","article-title":"The natural history of hip development in cerebral palsy","volume":"54","author":"Terjesen","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.pmr.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archneur.1982.00510170053016","article-title":"Carpal tunnel syndrome in athetoid-dystonic cerebral palsy","volume":"39","author":"Alvarez","year":"1982","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ageing\/27.2.239","article-title":"Management of spasticity","volume":"27","author":"Barnes","year":"1998","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.pmr.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1345\/aph.17302","article-title":"Selective serotonin-reuptake inhibitor-induced movement disorders","volume":"32","author":"Gerber","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1191\/0269215506cr922oa","article-title":"The Tardieu scale differentiates contracture from spasticity whereas the Ashworth scale is confounded by it","volume":"20","author":"Patrick","year":"2006","journal-title":"Clin Rehabil"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/0883073813483903","article-title":"Further evaluation of the scoring, reliability, and validity of the hypertonia assessment tool (HAT)","volume":"29","author":"Knights","year":"2014","journal-title":"J\u00a0Child Neurol"},{"issue":"5","key":"10.1016\/j.pmr.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-8749.2009.03477.x","article-title":"Development of the hypertonia assessment tool (HAT)","volume":"52","author":"Albright","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1302\/0301-620X.57B2.160","article-title":"Surgical prophylaxis of subluxation and dislocation of the hip in cerebral palsy","volume":"57","author":"Sharrard","year":"1975","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3944\/AOTT.2009.081","article-title":"Management of spasticity in children with cerebral palsy","volume":"43","author":"Matthews","year":"2009","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"5","key":"10.1016\/j.pmr.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/toxins7051629","article-title":"Best clinical practice in botulinum toxin treatment for children with cerebral palsy","volume":"7","author":"Strobl","year":"2015","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.pmr.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01241398-198411000-00012","article-title":"Pre- and postoperative gait analysis in patients with spastic diplegia: a preliminary report","volume":"4","author":"Gage","year":"1984","journal-title":"J\u00a0Pediatr Orthop"},{"key":"10.1016\/j.pmr.2018.03.002_bib20","unstructured":"Center for cerebral palsy spasticity. Available at: http:\/\/www.stlouischildrens.org\/our-services\/center-cerebral-palsy-spasticity\/patient-selection. Accessed December 29th, 2017."},{"key":"10.1016\/j.pmr.2018.03.002_bib21","unstructured":"About the therapy intrathecal baclofen therapy with lioresal intrathecal (baclofen injection). Medtronic Web site. Available at: https:\/\/www.medtronic.com\/us-en\/healthcare-professionals\/therapies-procedures\/neurological\/intrathecal-baclofen-therapy\/education-training\/about-the-therapy.html. Updated 2017. Accessed December 29th, 2017."},{"issue":"1","key":"10.1016\/j.pmr.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/PHM.0b013e31823caae1","article-title":"Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure","volume":"91","author":"Balaban","year":"2012","journal-title":"Am J Phys Med Rehabil"},{"issue":"10","key":"10.1016\/j.pmr.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1469-8749.2011.03992.x","article-title":"Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review","volume":"53","author":"Pin","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000358307","article-title":"Complications of intrathecal baclofen pumps in children: experience from a tertiary care center","volume":"49","author":"Ghosh","year":"2013","journal-title":"Pediatr Neurosurg"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2009.09.005","article-title":"The updated European consensus 2009 on the use of botulinum toxin for children with cerebral palsy","volume":"14","author":"Heinen","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ridd.2012.11.016","article-title":"Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: muscle atrophy after motor end plate-targeted injections","volume":"34","author":"Van Campenhout","year":"2013","journal-title":"Res Dev Disabil"},{"issue":"Suppl 1","key":"10.1016\/j.pmr.2018.03.002_bib27","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1177\/0883073803018001S0701","article-title":"Injectable neuromuscular blockade in the treatment of spasticity and movement disorders","volume":"18","author":"Tilton","year":"2003","journal-title":"J\u00a0Child Neurol"},{"issue":"7","key":"10.1016\/j.pmr.2018.03.002_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.0b013e3181ec670b","volume":"75","author":"Whelan","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pmr.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1469-8749.1980.tb03742.x","article-title":"Dantrolene sodium suspension in treatment of spastic cerebral palsy","volume":"22","author":"Joynt","year":"1980","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00003495-197713010-00002","article-title":"Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity","volume":"13","author":"Pinder","year":"1977","journal-title":"Drugs"},{"issue":"98","key":"10.1016\/j.pmr.2018.03.002_bib31","first-page":"237","article-title":"New indication. Cerebral palsy in children: uncertain clinical benefit","volume":"17","author":"Dantrolene","year":"2008","journal-title":"Prescrire Int"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.002_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.0b013e3181cbcd2f","volume":"74","author":"Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.002_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejpn.2016.04.008","article-title":"Safety profile of incobotulinum toxin A [xeomin((R))] in gastrocnemious muscles injections in children with cerebral palsy: randomized double-blind clinical trial","volume":"20","author":"Carraro","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.pmr.2018.03.002_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.12659\/AJCR.893805","article-title":"Platelet-rich plasma in a patient with cerebral palsy","volume":"16","author":"Alcaraz","year":"2015","journal-title":"Am J Case Rep"},{"issue":"9","key":"10.1016\/j.pmr.2018.03.002_bib35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00381-007-0396-4","article-title":"Nonoperative management of spasticity in children","volume":"23","author":"Ronan","year":"2007","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"10.1016\/j.pmr.2018.03.002_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.pmrj.2015.05.020","article-title":"A\u00a0retrospective review of unintended effects after single-event multi-level chemoneurolysis with botulinum toxin-A and phenol in children with cerebral palsy","volume":"7","author":"Ploypetch","year":"2015","journal-title":"PM R"},{"issue":"11","key":"10.1016\/j.pmr.2018.03.002_bib37","article-title":"Intrathecal baclofen for treating spasticity in children with cerebral palsy","author":"Hasnat","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.002_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ner.12220","article-title":"Medical cost impact of intrathecal baclofen\u00a0therapy for severe spasticity","volume":"18","author":"Saulino","year":"2015","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.pmr.2018.03.002_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3171\/2013.11.PEDS13253","article-title":"Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience","volume":"13","author":"Motta","year":"2014","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.002_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.bpo.0000191555.11326.bd","article-title":"Rapid progression of scoliosis following insertion of intrathecal baclofen pump","volume":"26","author":"Sansone","year":"2006","journal-title":"J\u00a0Pediatr Orthop"},{"issue":"21","key":"10.1016\/j.pmr.2018.03.002_bib41","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1097\/BRS.0b013e3181557252","article-title":"The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy","volume":"32","author":"Senaran","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"issue":"9","key":"10.1016\/j.pmr.2018.03.002_bib42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.pmrj.2009.07.016","article-title":"Surgical management of spasticity in persons with cerebral palsy","volume":"1","author":"Lynn","year":"2009","journal-title":"PM R"},{"issue":"9","key":"10.1016\/j.pmr.2018.03.002_bib43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00381-007-0379-5","article-title":"Selective dorsal rhizotomy for spastic cerebral palsy: a review","volume":"23","author":"Steinbok","year":"2007","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"10.1016\/j.pmr.2018.03.002_bib44","first-page":"e1256","article-title":"Functional outcomes of childhood selective dorsal rhizotomy 20 to 28 years later","volume":"9","author":"Park","year":"2017","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.pmr.2018.03.002_bib45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/BPO.0b013e31815b4d7d","article-title":"A\u00a0pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus","volume":"27","author":"Newman","year":"2007","journal-title":"J\u00a0Pediatr Orthop"},{"issue":"Suppl 1","key":"10.1016\/j.pmr.2018.03.002_bib46","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.3727\/096368912X633798","article-title":"Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life","volume":"21","author":"Sharma","year":"2012","journal-title":"Cell Transplant"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.002_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jcyt.2014.10.011","article-title":"Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety","volume":"17","author":"Zali","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.pmr.2018.03.002_bib48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ridd.2014.12.017","article-title":"Effects of an eight-week whole body vibration on lower extremity muscle tone and function in children with cerebral palsy","volume":"38","author":"Cheng","year":"2015","journal-title":"Res Dev Disabil"},{"issue":"19","key":"10.1016\/j.pmr.2018.03.002_bib49","doi-asserted-by":"crossref","first-page":"e3649","DOI":"10.1097\/MD.0000000000003649","article-title":"A\u00a0prospective case-control study of radial extracorporeal shock wave therapy for spastic plantar flexor muscles in very young children with cerebral palsy","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pmr.2018.03.002_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ctcp.2016.02.002","article-title":"Horseback riding therapy in addition to conventional rehabilitation program decreases spasticity in children with cerebral palsy: a small sample study","volume":"23","author":"Alemdaroglu","year":"2016","journal-title":"Complement Ther Clin Pract"},{"key":"10.1016\/j.pmr.2018.03.002_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fped.2015.00074","article-title":"Myofascial structural integration therapy on gross motor function and gait of young children with spastic cerebral palsy: a randomized controlled trial","volume":"3","author":"Loi","year":"2015","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pmr.2018.03.002_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clineuro.2015.05.017","article-title":"Deep anterior cerebellar stimulation reduces symptoms of secondary dystonia in patients with cerebral palsy treated due to spasticity","volume":"135","author":"Sokal","year":"2015","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965118307605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965118307605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:40:05Z","timestamp":1760931605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965118307605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1047965118307605"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2018.03.002","relation":{},"ISSN":["1047-9651"],"issn-type":[{"type":"print","value":"1047-9651"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special Considerations in Pediatric Assessment","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}